ALS pathological mediator identified by researchers
A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
List view / Grid view
A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
A study has used EEG to investigate the neuron networks that act abnormally in the condition, providing a significant step in the search for treatments.
Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use.
Strathmin2 could be used as a biomarker for amyotrophic lateral sclerosis (ALS), a debilitating condition with no proper diagnostic tests or treatments...
Researchers have made discoveries about the formation of cellular components called membraneless organelles and the key role these organelles play in cells...
PARP inhibitors show promise in preventing toxic accumulations of brain disease proteins in Penn research study...
Previous studies have suggested that a gene therapy drug may be used to treat ALS...
A new Tel Aviv University study identifies a previously unknown mechanism involved in the development of Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS).
A study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of aggressive ALS...
Broad data analysis points to genetic similarities between Lou Gehrig's Disease and a form of dementia...
An international team of researchers has identified a new gene associated with the development of amyotrophic lateral sclerosis...
Study provides a roadmap for using CRISPR to investigate neurological disorders...
Understanding how motor nerve cells respond to motor neurone disease could help researchers identify new treatment options...
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease by stopping toxic ion flow in the brain...
Scientists may have found possible targets for therapeutic interventions in the fight against Lou Gehrig’s disease.